Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. Dezember 2025 08:30 ET | Quelle: Stemline Therapeutics, Inc.

Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as well as in both metastatic and early...
23. Dezember 2022 08:00 ET | Quelle: Immutep Limited

Immutep Announces Successful Meeting with the FDA on Eftilagimod Alpha plus Chemotherapy for the Treatment of Metastatic Breast Cancer

Agreement with FDA on Phase II/III trial design positions the Company to exploit eftilagimod alpha’s potential to address high unmet need for metastatic breast cancer patientsPatient population...
07. September 2017 10:57 ET | Quelle: Premier Exhibitions, Inc.

LIVE FROM CHICAGO, It’s Saturday Night Live: The Experience

CHICAGO, Sept. 07, 2017 (GLOBE NEWSWIRE) -- The Museum of Broadcast Communications in collaboration with Universal Brand Development, Saturday Night Live, Broadway Video Enterprises and Premier...